Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Lucky Charms™, Strawberry Blossom, Oatmilk, Tropical Peach, and Crème Cold Brew Highlight Spring Menu at Scooter’s Coffee
-
Fueled by Micron Mobile Solutions, Samsung Galaxy S25 Series Raises the Bar for AI Experiences
-
New Lily AI Consumer Research Reveals Product Details, or Lack Thereof, Are a Problem for Retailers
-
Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
-
Cordelio Power and Fluence Partner to Deploy 1 GWh of Domestically Manufactured Battery Storage Systems Starting in 2026
-
Seraphic Security Embraces Channel-First Strategy to Scale Operations in 2025
-
Quantum Computing Solutions Big Influence on Commercial & Military Drone Applications Drastically Improving Operations
-
Two AdTech Industry Experts Join Compliant’s Board of Advisors as Data Compliance Gains Industry Traction
-
Exodus Expands Crypto Access to Venmo Users Through MoonPay Integration
-
Potbelly Sandwich Works Announces Six New Shops in Winston-Salem Market Expansion
-
Ezra Announces New FDA Clearance, Enhancing the Capabilities of Its Full-Body Scan Technology
-
Intapp DealCloud named Deal Origination Solution of the Year: Credit at the Private Equity Wire European Awards 2025
-
Orion180 Makes Key Executive Moves to Drive Product Growth and Further Expansion
-
Lucidworks Launches AI-Powered Commerce Studio and Analytics Studio, Available in New Fast-Start Packages
-
CANADIAN BANC CORP. Monthly Dividend Declaration for Class A & Preferred Share
-
HWH International Inc. Announces Reverse Stock Split
-
BsvCloud Launches 2025 Mining Contracts, Offering New Passive Income Opportunities through Cloud Mining
-
Greenheart Gold Has Entered Into an Option Agreement to Acquire a 100% Interest in the Tosso Creek Exploration Project in Suriname
-
SELLAS Announces Positive Data from Phase 2a Trial of SLS009 in Combination with Zanubrutinib in DLBCL
-
Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada’s SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis (UC)
-
Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada’s SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis (UC)
-
Orbit International’s Electronics Group Reports Contract Award in Excess of $1,925,000
-
Grabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of Akero Therapeutics, Inc. (NASDAQ: AKRO); Crocs, Inc. (NASDAQ: CROX); Extreme Networks, Inc. (NASDAQ: EXTR); and Domino�
-
Grabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of MGP Ingredients, Inc. (NASDAQ: MGPI); ModivCare, Inc. (NASDAQ: MODV); Monolithic Power Systems, Inc. (NASDAQ: MPWR); an
-
SKYX Will Supply Its Advanced Smart Plug & Play Technologies to Three Upcoming Ultra-High-End Luxury Projects of Forte Developments
-
OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis
-
Verifone and PopID Partner to Drive Adoption of Biometric Payments and Loyalty
-
Phoenix Energy Acquires Over $10 Million in Premier North Dakota Oil and Gas Leases
-
Birchtech Secures New Agreement with Power Utility from Arizona Litigation
-
Reborn Coffee Dubai Drives European Flagship Expansion into Vienna, Florence, And Prague
-
AmpliTech Group Announces Innovative True 5G Technology Development
-
Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock
-
UAV Corp Unveils AIG’s Arrival and Cutting-Edge 3D Printing Technology, Paving the Way for Full-Scale T-Wing UAS Production and the Future of Aerospace and Defense Manufacturing
-
Comscore Expands YouTube CTV Viewership Measurement to International Markets
-
KULR Achieves AS9100 Certification
-
Hudson Technologies to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Results
-
Aphaia Pharma to Participate in Panel Discussion at SXSW 2025
-
Independent Proxy Advisory Firms Recommend Quisitive Shareholders Vote for the Proposed Acquisition by H.I.G. Capital
-
Golden Grail Beverages Announces Termination of UPDC Beverages Asset Purchase Agreement
-
Where Food Comes From, Inc. Reports 2024 Fourth Quarter and Full Year Financial Results
-
REE Automotive Collaborates with Geotab to Provide Advanced Data Analytics to Fleets
-
Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting
-
IMUNON to Hold 2024 Financial Results and Business Update Conference Call on Thursday, February 27, 2025
-
Verizon Innovative Learning reaches 8.5 million students, adds 34 schools for 2025-2026 school year
-
The Rational Special Situations Income Fund (RFXIX) Surpasses $1 Billion in Assets Under Management
-
Giftify, Inc. Announces Smart Savings Solution for Popular GLP-1 Diabetes and Weight Loss Medications
-
PolarityBio Receives U.S. FDA Breakthrough Therapy Designation for Treatment of Wagner Grade I Diabetic Foot Ulcers (DFU)
-
Intuitive Machines IM-2 Mission Lunar Lander Encapsulated and Scheduled for Launch
-
BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program
-
Climb Global Solutions Sets Fourth Quarter and Full Year 2024 Conference Call for March 6, 2025 at 8:30 a.m. ET
